Navigation Links
Covance Reports Fourth Quarter Revenue of $532M, GAAP EPS of $0.35, Pro Forma EPS of $0.73, and Adjusted Net Orders of $759M
Date:1/25/2012

Operating Income

$39.0

$28.9

35.0%

$180.6

$47.5

280.3%Net Income

$21.1

$28.4

(25.5%)

$132.2

$68.3

93.7%Earnings Per Share

$0.35

$0.45

(23.6%)

$2.16

$1.06

104.3%2011 Charges*

($31.1)

-($46.8)

-2010 Charges*

-

($18.4)-

($137.6)Favorable Income Tax items*

$1.8

$6.9$2.5

$17.3Operating Income, excluding items*

$57.9

$47.2

22.6%

$215.3

$185.1

16.3%  Operating Margin %, ex items*

10.9%

9.6%10.3%

9.6%Net Income, excluding items*

$44.6

$35.1

26.9%

$165.0

$138.6

19.1%Diluted EPS, excluding items*

$0.73

$0.56

30.4%

$2.70

$2.15

25.7%* See attached pro forma income statements for reconciliation of GAAP to pro forma amounts.

Operating Segment Results Early Development($ in millions)4Q114Q10ChangeFY 2011FY 2010ChangeNet Revenues

$234.5

$220.6

6.3%

$930.6

$840.3

10.7%GAAP Operating Income (Loss)

$17.7

$21.1

(16.3%)

$105.3

($32.0)

-GAAP Operating Margin %

7.5%

9.6%11.3%

(3.8%)2011 Charges

($15.0)

-($21.7)

-2010 Charges

-

($5.4)-

($124.6)2010 Cost Actions

-

--

($8.0)Pro Forma Operating Income

$32.6

$26.6

22.8%

$127.0

$100.7

26.1%Pro Forma OM%

13.9%

12.0%13.7%

12.0%The Early Development segment includes preclinical toxicology, analytical chemistry, clinical pharmacology, discovery support, and research products.  Net revenues in the fourth quarter of 2011 grew 6.3% year-on-year to $234.5 million, driven by the results from our new Alnwick, UK and Porcheville, France sites and clinical p
'/>"/>

SOURCE Covance Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Covance Decides to Pursue Its Original Preclinical Strategy in China
2. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
3. Covance Purchases Equity Stake in Caprion Proteomics
4. Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
5. Jina Ventures Advises Swiss Pharma Contract on Strategic Sale to Covance Inc
6. Covance Opens New Clinical Development Offices in Chile, Peru and Expands Argentina Office
7. Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
8. Covance Elects John McCartney to Companys Board of Directors
9. Covance to Present at the Drug Information Associations 45th Annual Meeting
10. Covance Appoints Dr. Steven M. Michael as Vice President and Chief Scientific Officer of Global Bioanalytical Services
11. Covance to Sell Its Interactive Voice and Web Response Services and Enter Into a Multi-Year Marketing Agreement with Phase Forward
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 21, 2014 RURO, Inc., a ... has released Limfinity® version 5.1.4. , RURO’s deployment ... Limfinity® than ever in RURO’s 8 year history. ... framework enhancement. Limfinity® version 5.1.4 is the perfect ... beyond bug fixes! , Limfinity® 5.1.4 release highlights ...
(Date:11/22/2014)... -- The element of surprise has been a major advantage ... warning. Until now, epidemiologists had nothing to measure that ... in suboptimal responses to both the H1N1 pandemic of ... - http://photos.prnewswire.com/prnh/20141121/160242 That virus ... gene structural changes have been found that invariably to ...
(Date:11/21/2014)... 19, 2014 The science of light ... shared with more than 200 primary students in a ... the University of Otago Physics Department and funded by ... students, members of the university’s OSA/SPIE Student Chapter visited ... September, giving children from small, rural schools hands-on lessons ...
(Date:11/21/2014)... The report, "Synthetic Biology Market ... kits), Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning ... - Global Forecast to 2018", analyses and ... and challenges. , Browse 99 market data ... pages and in-depth TOC of the global ...
Breaking Biology Technology:RURO Announces Limfinity® version 5.1.4 2Viruses' Advantage of Surprise is Lost 2Optics and photonics outreach programs share science, spark fascination with light 2Optics and photonics outreach programs share science, spark fascination with light 3Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 2Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 3Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 4
... Prepare your probe in less , ... Ideal for siRNA/miRNA studies , , ... activity RNA probes for RPA, Northern, Southern, or in situ hybridization , ... No cloning required , With ...
... Reagents and , ... Superior identification of target cells provided ... Designed for use , ... Compatible with Arcturus LCM Systems , Use with , ...
... Now it's easy to make your RNA free of genomic DNA , ... , & Removal Reagents contain RNase-free DNase, ... to ensure safe, complete removal of , ... DNase Removal Reagent which, after digestion, eliminates DNase in , ...
Cached Biology Technology:Prepare siRNA and miRNA Probes in Just 1 Hour 2Prepare siRNA and miRNA Probes in Just 1 Hour 3Protect RNA and Improve Target Cell Identification 2Protect RNA and Improve Target Cell Identification 3Protect RNA and Improve Target Cell Identification 4Protect RNA and Improve Target Cell Identification 5Protect RNA and Improve Target Cell Identification 6DNA-free A NEW Method to Remove DNA 2DNA-free A NEW Method to Remove DNA 3DNA-free A NEW Method to Remove DNA 4DNA-free A NEW Method to Remove DNA 5DNA-free A NEW Method to Remove DNA 6DNA-free A NEW Method to Remove DNA 7DNA-free A NEW Method to Remove DNA 8
(Date:11/15/2014)... YORK , Nov. 13, 2014  While we may ... technology Doctor McCoy used in "Star Trek" to gain instant ... tools designed to work with smartphones and tablets for monitoring ... of the healthcare world. This may seem a tad Orwellian ... ready to adopt some of these technological opportunities into their ...
(Date:11/7/2014)... conjunction with the Glendale and ... the Verdugos has announced the " GLENDALE - ... to keep the Verdugo Regional Crime Lab operational after its ... existence, the Lab has processed more than 400 DNA samples, ... "Because our number one priority is the wellbeing of ...
(Date:11/6/2014)... - Insilico Medicine, Inc, a Baltimore-based bioinformatics company ... diseases announced a research collaboration with the international ... Inc (OTC: CSBR). , "There are many companies ... Champions Oncology,s TumorGraft technology is unique in a ... experimentally generating vast amounts of valuable data. Our ...
Breaking Biology News(10 mins):Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2
... have resolved the debate over the mechanisms involved in the ... Research findings, published in the journal PNAS , ... this shut-down process to ensure that viruses and other pathogens ... harm. Previous research has shown that when cells divide, ...
... Huntington Beach, CAThe Association for Chemoreception Sciences (AChemS), a US-based ... 500 scientists are gathering to present new information on the ... nutrition, and social interactions in humans as ... in our daily lives. These ...
... dinosaurs that lived within Arctic latitudes approximately 70 million ... of migrating to more southern latitudes, a recent study ... of Nature and Science in Dallas and Temple University ... Were Perennial Polar Residents," in the April issue of ...
Cached Biology News:Study resolves debate on human cell shut-down process 2Smell and taste experts to discuss new discoveries 2Smell and taste experts to discuss new discoveries 3Smell and taste experts to discuss new discoveries 4Duck-billed dinosaurs endured long, dark polar winters 2Duck-billed dinosaurs endured long, dark polar winters 3